Stay updated on Moderna Press Releases

Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Moderna Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    Footer copyright notice updated from © 2025 Moderna, Inc. to © 2026 Moderna, Inc. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-30T03:08:17.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    150 days ago
    Change Detected
    Summary
    The page has updated key financial figures and important legal news regarding Moderna, including a decrease in stock price and a confirmation of patent validity against Pfizer/BioNTech.
    Difference
    100%
    Check dated 2025-08-08T09:20:41.000Z thumbnail image
  6. Check
    157 days ago
    Change Detected
    Summary
    The page has updated key information regarding Moderna's COVID-19 vaccine, including a new price of $29.56 and the European Commission's approval for the updated vaccine targeting the SARS-CoV-2 variant LP.8.1, while previous pricing and several earlier announcements have been removed.
    Difference
    98%
    Check dated 2025-08-01T06:23:48.000Z thumbnail image
  7. Check
    164 days ago
    Change Detected
    Summary
    The pricing has increased from $32.20 to $34.01, and stock availability has risen from 6.01M to 6.61M.
    Difference
    3%
    Check dated 2025-07-25T01:31:32.000Z thumbnail image
  8. Check
    172 days ago
    Change Detected
    Summary
    Moderna has received U.S. FDA approval for its RSV vaccine, mRESVIA, for adults aged 18-59 at increased risk for RSV disease, while the previous approval for its COVID-19 vaccine, Spikevax, in children has been removed from the page.
    Difference
    82%
    Check dated 2025-07-17T20:32:42.000Z thumbnail image
  9. Check
    179 days ago
    Change Detected
    Summary
    The page now displays 26 news items from the year 2025, including the significant addition of Moderna receiving full U.S. FDA approval for its COVID-19 vaccine for children at increased risk.
    Difference
    7%
    Check dated 2025-07-10T16:38:46.000Z thumbnail image

Stay in the know with updates to Moderna Press Releases

Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.